Social Media Content Creators Fueling Parallel Market for Unapproved Weight-Loss Drug

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several experts stated the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Removal

According to TikTok, the platform has taken down problematic material and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

After moments of entering one community, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially significant health risks”.